70 lines
5.5 KiB
Markdown
70 lines
5.5 KiB
Markdown
---
|
|
type: source
|
|
title: "CMS Terminates Medicare Advantage VBID Model: End of Primary Food-as-Medicine Funding Vehicle"
|
|
author: "Centers for Medicare and Medicaid Services"
|
|
url: https://www.cms.gov/blog/medicare-advantage-value-based-insurance-design-vbid-model-end-after-calendar-year-2025-excess-costs
|
|
date: 2024-10-31
|
|
domain: health
|
|
secondary_domains: [internet-finance]
|
|
format: announcement
|
|
status: unprocessed
|
|
priority: high
|
|
tags: [vbid, cms, medicare-advantage, food-as-medicine, payment-policy, supplemental-benefits, ssbci]
|
|
flagged_for_rio: ["CMS VBID termination is a major payment model policy shift — intersects with Rio's VBC and MA economics analysis"]
|
|
---
|
|
|
|
## Content
|
|
|
|
CMS announced termination of the Medicare Advantage Value-Based Insurance Design (VBID) Model at end of Calendar Year 2025, citing unmitigable excess costs to Medicare Trust Funds.
|
|
|
|
**Financial rationale:**
|
|
- Excess costs: $2.3 billion in CY2021, $2.2 billion in CY2022 above expected
|
|
- "Excess costs of this magnitude are unprecedented in CMS Innovation Center models"
|
|
- No viable policy modifications identified to address excess costs
|
|
- Costs driven by increased risk score growth and Part D expenditures
|
|
|
|
**Food-as-medicine impact:**
|
|
- Food/nutrition assistance was the most common VBID supplemental benefit in 2024
|
|
- VBID had been the primary vehicle for MA plans to offer food-as-medicine benefits to low-income enrollees
|
|
- ~2,000 MA plans participated in VBID at peak
|
|
|
|
**Post-termination pathway (SSBCI):**
|
|
- MA plans can continue offering food benefits through Supplemental Benefit for the Chronically Ill (SSBCI) pathway
|
|
- BUT: SSBCI does NOT allow eligibility based on low income or living in communities of socioeconomic disadvantage
|
|
- SSBCI only qualifies beneficiaries with chronic conditions — eligibility criteria narrow
|
|
- This effectively eliminates food-as-medicine access for the core target population (food-insecure, low-income, not necessarily chronically ill)
|
|
|
|
**Section 1115 waiver review:**
|
|
- 6 of 8 states with active 1115 waivers for food-as-medicine programs were placed under CMS review
|
|
- Extent to which Trump administration will approve FIM funding through waivers "uncertain"
|
|
|
|
**Timeline:**
|
|
- Biden administration announced termination: October/November 2024
|
|
- VBID ends: December 31, 2025
|
|
- Trump administration inherited the termination decision; food-policy rhetoric (MAHA) does not reverse the payment infrastructure cuts
|
|
|
|
## Agent Notes
|
|
|
|
**Why this matters:** This is the single most important policy event in the food-as-medicine space since the White House Conference on Hunger. VBID was the operational funding mechanism for food benefits in MA — its termination removes the payment infrastructure at the exact moment rhetorical support for food-as-medicine is highest. This is the structural misalignment pattern from previous sessions playing out in real time: the payment system fails the intervention even when the rhetoric succeeds.
|
|
|
|
**What surprised me:** The VBID termination was a Biden administration decision (not Trump). The $2.3-2.2B annual excess costs are genuinely alarming — this wasn't a marginal overpayment. And the SSBCI replacement explicitly removes the socioeconomic eligibility criteria, which makes the replacement pathway unusable for the core food-insecure population. This is worse than just ending the program — it's ending the program and replacing it with something that excludes the target population by design.
|
|
|
|
**What I expected but didn't find:** Any evidence that CMS is developing an alternative mechanism to preserve food benefits for low-income MA enrollees. The gap is real.
|
|
|
|
**KB connections:**
|
|
- Directly extends the March 12 session's finding: MA plans restrict GLP-1s despite capitation incentives. Now: MA plans will lose the payment mechanism for food benefits entirely.
|
|
- Connects to the "structural misalignment" theme across all VBC sessions: payment reform is necessary but not sufficient, and payment REFORM can go backwards.
|
|
- Connects to the "value-based care transitions stall at the payment boundary" claim — this is an example of the payment boundary rolling back.
|
|
|
|
**Extraction hints:**
|
|
- "CMS VBID termination removes the primary payment mechanism for food-as-medicine under Medicare Advantage, and the SSBCI replacement excludes low-income eligibility criteria" — this is a concrete, falsifiable, policy-state claim
|
|
- The mismatch between MAHA rhetoric and VBID termination reality is extractable as a political economy claim
|
|
- The $2.3B excess cost figure is important context: it was the justification for termination, but also evidence that food/supplemental benefits were heavily utilized
|
|
|
|
**Context:** The VBID model was a CMS Innovation Center model that allowed MA plans to offer supplemental benefits including food, transportation, and housing assistance. It was widely used and represented the most significant expansion of non-medical benefits in Medicare history. Its termination is a major contraction of the policy experiment.
|
|
|
|
## Curator Notes
|
|
|
|
PRIMARY CONNECTION: The structural misalignment claim in VBC (payment boundary stalls) — this is a new instance where the payment infrastructure for non-clinical intervention is contracting
|
|
WHY ARCHIVED: Policy event that changes the funding landscape for food-as-medicine — essential context for any claim about FIM scalability or the attractor state toward prevention
|
|
EXTRACTION HINT: Extract the payment mechanism claim (VBID ends, SSBCI excludes low-income) as a concrete policy-state change. Also flag the MAHA rhetoric vs. funding reality as a cross-domain political economy observation.
|